Beadassay – Multiplex Antibody Detection and Advanced Analysis

Fluorescence-based diagnostic assays for medical testing and analysis. Designed for integration with optical sensor systems and imaging equipment.

A single channel fluorescent immunoanalyzer utilizing Quantum Dots immunofluorescence technology for point-of-care testing. Offers high-speed analysis at 120 tests per hour with ultra-high sensitivity and exceptional stability for in vitro diagnostics applications.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

An immunofluorescence analyzer for automated diagnostic testing in medical laboratories. The device performs fluorescence-based immunoassay analysis for various medical testing applications.

Biochemistry-based colorimetric detection assays for medical diagnostics. Integrated with hybrid sensor systems for optical signal acquisition and analysis.

A fluorescence immunochromatography analyzer for diagnostic testing purposes. This device is registered under the medical device approval number Jing 械注准20172220703. It performs immunochromatographic assays using fluorescence detection technology for clinical laboratory analysis.

A fluorescence immunoassay analyzer for biochemical and immunological testing. This device performs automated immunoassay analysis using fluorescence detection technology.

Advanced immunofluorescence assays designed for precise tracking of biomarkers related to diabetes, hormones, inflammation/coagulation, cardiovascular and bone health. These assays are compatible with the Qassay Digital Rapid Test Reader platform.

Fluorescence immunochromatography analyzer for rapid point-of-care testing (POCT) and clinical diagnostics. Detects biomarkers and analytes using fluorescence-based immunoassay technology for disease screening and monitoring. Integrates with chronic disease management systems for automated result processing and data management.

A quantitative, multiplex in-vitro test system for sensitive and reliable identification of pathogen-specific antibodies using Luminex® multiplex technology. The system combines advantages of ELISA and line assays while employing proven, highly-specific recombinant antigens. Integrated controls provide very high measurement accuracy and reproducibility, making it ideal as a confirmation test for high sample throughput with fully automatic evaluation.

Diagnostic test kits utilizing fluorescence immunoassay technology for rapid detection of various health conditions. These tests are companion products to the fluorescence analyzer platform.

Freeze-dried RT-LAMP reagent beads combining colorimetric and fluorescence detection in single format. Enables dual-platform readout for confirmatory diagnostics and research applications. Pre-formulated with all necessary amplification and detection components.